RNA-Based Technologies for Engineering Plant Virus Resistance

被引:36
作者
Taliansky, Michael [1 ,2 ]
Samarskaya, Viktoria [1 ]
Zavriev, Sergey K. [1 ]
Fesenko, Igor [1 ]
Kalinina, Natalia O. [1 ,3 ]
Love, Andrew J. [2 ]
机构
[1] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia
[2] James Hutton Inst, Dundee DD2 5DA, Scotland
[3] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia
来源
PLANTS-BASEL | 2021年 / 10卷 / 01期
关键词
dsRNA; siRNA; miRNA; lncRNA; amiRNA; tasiRNA; RNAi; CRISPR-Cas;
D O I
10.3390/plants10010082
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
In recent years, non-coding RNAs (ncRNAs) have gained unprecedented attention as new and crucial players in the regulation of numerous cellular processes and disease responses. In this review, we describe how diverse ncRNAs, including both small RNAs and long ncRNAs, may be used to engineer resistance against plant viruses. We discuss how double-stranded RNAs and small RNAs, such as artificial microRNAs and trans-acting small interfering RNAs, either produced in transgenic plants or delivered exogenously to non-transgenic plants, may constitute powerful RNA interference (RNAi)-based technology that can be exploited to control plant viruses. Additionally, we describe how RNA guided CRISPR-CAS gene-editing systems have been deployed to inhibit plant virus infections, and we provide a comparative analysis of RNAi approaches and CRISPR-Cas technology. The two main strategies for engineering virus resistance are also discussed, including direct targeting of viral DNA or RNA, or inactivation of plant host susceptibility genes. We also elaborate on the challenges that need to be overcome before such technologies can be broadly exploited for crop protection against viruses.
引用
收藏
页码:1 / 19
页数:19
相关论文
共 50 条
  • [31] Insight into RNA-based Therapies for Ovarian Cancer
    Keyvani, Vahideh
    Mahmoudian, Reihaneh Alsadat
    Mollazadeh, Samaneh
    Kheradmand, Nahid
    Ghorbani, Elnaz
    Khazaei, Majid
    Al-Hayawi, Ibrahim Saeed
    Hassanian, Seyed Mahdi
    Ferns, Gordon A.
    Avan, Amir
    Anvari, Kazem
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (34) : 2692 - 2701
  • [32] The potential of RNA-based therapy for kidney diseases
    Bondue, Tjessa
    van den Heuvel, Lambertus
    Levtchenko, Elena
    Brock, Roland
    [J]. PEDIATRIC NEPHROLOGY, 2023, 38 (02) : 327 - 344
  • [33] Theranostic Nanoparticles for RNA-Based Cancer Treatment
    Revia, Richard A.
    Stephen, Zachary R.
    Zhang, Miqin
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2019, 52 (06) : 1496 - 1506
  • [34] RNA-based mechanisms regulating hostvirus interactions
    Zhou, Rui
    Rana, Tariq M.
    [J]. IMMUNOLOGICAL REVIEWS, 2013, 253 : 97 - 111
  • [35] RNA-based scaffolds for bone regeneration: application and mechanisms of mRNA, miRNA and siRNA
    Leng, Qiuping
    Chen, Lini
    Lv, Yonggang
    [J]. THERANOSTICS, 2020, 10 (07): : 3190 - 3205
  • [36] Small interfering RNA-based nanotherapeutics for treating skin-related diseases
    Chang, Yen-Tzu
    Huang, Tse-Hung
    Alalaiwe, Ahmed
    Hwang, Erica
    Fang, Jia-You
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2023, 20 (06) : 757 - 772
  • [37] An integrated approach for mining precise RNA-based cervical cancer staging biomarkers
    Banerjee, Satarupa
    Karunagaran, Devarajan
    [J]. GENE, 2019, 712
  • [38] RNA-based regulation in bacteria-phage interactions
    Saunier, Marion
    Fortier, Louis -Charles
    Soutourina, Olga
    [J]. ANAEROBE, 2024, 87
  • [39] Intracellular delivery of RNA-based therapeutics using aptamers
    Thiel, Kristina W.
    Giangrande, Paloma H.
    [J]. THERAPEUTIC DELIVERY, 2010, 1 (06) : 849 - 861
  • [40] RNA-Based Therapeutic Strategies for Inherited Retinal Dystrophies
    Garanto, Alejandro
    [J]. RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2019, 1185 : 71 - 77